Evidence map›Paper›PMID 39263013›Full record

ArticleTranslational lung cancer research2024

Clinical features and prognostic biomarkers in patients with

Jinyu Long, Ying Chen, Xingguang Luo, Ruiying Rao, Chenxi Wang, Yuxin Guo, Jinhe Xu, Ping Lin, Yingfang Song, Lijuan Qu and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Translational lung cancer research · 2025
    Article
  5. Translational lung cancer research · 2025
    Review
  6. Translational lung cancer research · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jinyu Long *Department of Respiratory and Critical Care Medicine, Fuzong Teaching Hospital, Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China.ORCID https://orcid.org/0009-0000-5547-456X
Ying Chen *Department of Respiratory and Critical Care Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, China.
Xingguang Luo *Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Ruiying RaoDepartment of Respiratory and Critical Care Medicine, Fuzong Teaching Hospital, Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China.
Chenxi WangFuzong Clinical Medical College, Fujian Medical University, Fuzhou, China.
Yuxin GuoFuzong Clinical Medical College, Fujian Medical University, Fuzhou, China.
Jinhe XuFuzong Clinical Medical College, Fujian Medical University, Fuzhou, China.
Ping LinDepartment of Respiratory and Critical Care Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, China.
Yingfang SongDepartment of Respiratory and Critical Care Medicine, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of China, Fuzhou, China.
Lijuan QuDepartment of Pathology, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, The 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou, China.
Qinghong LiuDepartment of Pathology, Fuzhou General Hospital of Fujian Medical University, Dongfang Hospital of Xiamen University, The 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou, China.
Jun LuThe Basic Medical Laboratory of the 900th Hospital of the Joint Logistics Support Force of the People's Liberation Army and the Key Laboratory of Transplantation Biology in Fujian Province, Fuzhou, China.
Chengzhi ZhouState Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Zhengbo SongDepartment of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Xiandong LinLaboratory of Radiation Oncology and Radiobiology, Clinical Oncology School of Fujian Medical University and Fujian Cancer Hospital, Fuzhou, China.
Hiroyuki AdachiDepartment of Surgery, Yokohama City University, Yokohama, Japan.
Jacek JassemDepartment of Oncology and Radiotherapy, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
Masatsugu HamajiDepartment of Thoracic and Cardiovascular Surgery, Nara Medical University, Kashihara, Japan.
Zongyang YuDepartment of Respiratory and Critical Care Medicine, Fuzong Teaching Hospital, Fujian University of Traditional Chinese Medicine (900th Hospital), Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with non-small cell lung cancer (NSCLC) carrying Methods: We used data from two cohorts of NSCLC- Results: The TCGA database included 480 patients with Conclusions:

Indexed as

clinical featuresNapsin ANon-small cell lung cancer (NSCLC)prognosisSMARCA4

Identifiers

PMID39263013
PMCPMC11384479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.